Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Data Collection Is Enabling CROs To Expand Service Offerings
Explore how innovative processes and advanced data collection technologies like ePRO and eCOA can help contract research organizations expand their service offerings.
-
Simplifying The Vineland-3: Assisting Raters, Reducing Burden, And Improving Data Quality
Electronic versions of both Vineland-II and Vineland-3 have been developed with features to improve data accuracy and consistency such as built-in prompts, item-specific scoring guidance, and automated calculations.
-
Different Stakeholder Perspectives On Navigating DHT Guidance
In a recent panel, industry leaders discussed the implications of FDA guidance for sponsors and developers implementing DHT as an innovative way to capture multidimensional patient data remotely.
-
AI In Clinical Trials: Practical Use Cases For Data Management
AI is improving daily data management with automation, faster issue detection, and smarter reviews. This piece outlines practical use cases and what teams need to enable real, sustainable adoption.
-
Advancing Neuromuscular Research with Digital Endpoints
Explore cutting-edge digital measures that capture peak mobility and activity in real-world settings, offering meaningful insights into disease progression in neuromuscular disorders.
-
How eCOA Improves Data Quality In Clinical Trials
eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.
-
Leveraging Real-World Patient Journeys At Scale For Clinical Trial Strategies
Unearth new ways to identify clinical trial patient populations, develop recruitment, access, and support strategies, and shape trial design and execution for success with real-world data and advanced solutions.
-
Hearing The Patient Voice Through Technology & eCOA
Discover the benefits of gathering patient data through electronic clinical outcome assessments and electronic patient-reported outcomes over paper versions.
-
Simply Digital: Trial Technologies Help Reduce Oncology's Burden
Oncology trials are notorious for presenting participants and sites with many challenges. With the FDA having put its support behind digital tools, learn how they make oncology trials easier for everyone.
-
Rare Disease Clinical Trials: Modern Design And Supply Chain
Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
RECENT NEWSLETTERS
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More